tiprankstipranks
Trending News
More News >
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
US Market
Advertisement

Adverum Biotechnologies (ADVM) Ratios

Compare
631 Followers

Adverum Biotechnologies Ratios

ADVM's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, ADVM's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.57 4.13 5.91 14.88 20.82
Quick Ratio
3.57 4.13 5.91 14.88 20.82
Cash Ratio
1.96 3.01 2.12 1.60 2.99
Solvency Ratio
-1.10 -1.25 -1.17 -1.14 -2.35
Operating Cash Flow Ratio
-4.46 -3.65 -3.35 -5.06 -3.80
Short-Term Operating Cash Flow Coverage
-15.49 -8.73 -8.16 -57.17 -17.73
Net Current Asset Value
$ -21.76M$ 13.23M$ 63.74M$ 193.60M$ 386.22M
Leverage Ratios
Debt-to-Assets Ratio
0.68 0.43 0.35 0.23 0.06
Debt-to-Equity Ratio
3.53 0.90 0.59 0.33 0.07
Debt-to-Capital Ratio
0.78 0.47 0.37 0.25 0.07
Long-Term Debt-to-Capital Ratio
0.76 0.44 0.00 0.00 0.00
Financial Leverage Ratio
5.21 2.07 1.70 1.39 1.11
Debt Service Coverage Ratio
-11.59 -11.74 -11.18 -77.04 -25.34
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
1.72 0.99 0.23 0.01 <0.01
Interest Debt Per Share
4.45 7.44 10.76 10.51 3.61
Net Debt to EBITDA
-0.52 >-0.01 -0.26 -0.49 0.28
Profitability Margins
Gross Profit Margin
441.88%-56.78%0.00%38.07%0.00%
EBIT Margin
4239.73%-3444.19%0.00%-1948.29%0.00%
EBITDA Margin
3226.35%-3424.94%0.00%-1878.60%0.00%
Operating Profit Margin
4693.08%-3581.72%0.00%-1948.29%0.00%
Pretax Profit Margin
4826.81%-3422.06%0.00%-1940.53%0.00%
Net Profit Margin
4827.46%-3254.58%0.00%-1940.53%0.00%
Continuous Operations Profit Margin
3328.50%-3392.11%0.00%-1940.53%0.00%
Net Income Per EBT
100.01%95.11%100.05%100.00%100.96%
EBT Per EBIT
102.85%95.54%98.30%99.60%98.68%
Return on Assets (ROA)
-91.18%-67.72%-50.11%-33.10%-24.35%
Return on Equity (ROE)
-122.67%-140.37%-85.14%-46.03%-27.05%
Return on Capital Employed (ROCE)
-108.40%-87.07%-56.91%-34.92%-25.55%
Return on Invested Capital (ROIC)
-101.79%-75.67%-51.95%-35.66%-25.30%
Return on Tangible Assets
-91.18%-67.72%-50.11%-33.10%-24.35%
Earnings Yield
-227.93%-154.33%-268.45%-84.35%-12.73%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 1.31 0.00
Payables Turnover
1.46 2.94 2.92 3.35 1.48
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
-0.06 0.05 0.00 0.06 0.00
Asset Turnover
-0.02 0.02 0.00 0.02 0.00
Working Capital Turnover Ratio
-0.03 0.03 0.00 0.02 0.00
Cash Conversion Cycle
-249.98 -124.23 -125.13 168.85 -246.67
Days of Sales Outstanding
0.00 0.00 0.00 277.84 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
249.98 124.23 125.13 108.99 246.67
Operating Cycle
0.00 0.00 0.00 277.84 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-5.35 -9.02 -10.89 -11.00 -9.31
Free Cash Flow Per Share
-5.37 -9.10 -12.08 -12.54 -10.70
CapEx Per Share
0.02 0.08 1.19 1.54 1.39
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.11 1.14 1.15
Dividend Paid and CapEx Coverage Ratio
-216.19 -112.50 -9.15 -7.13 -6.69
Capital Expenditure Coverage Ratio
-216.19 -112.50 -9.15 -7.13 -6.69
Operating Cash Flow Coverage Ratio
-1.20 -1.21 -1.01 -1.05 -2.58
Operating Cash Flow to Sales Ratio
43.07 -25.25 0.00 -14.38 0.00
Free Cash Flow Yield
-204.77%-120.80%-208.30%-71.26%-9.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.43 -0.65 -0.37 -1.19 -7.85
Price-to-Sales (P/S) Ratio
-20.81 21.09 0.00 23.01 0.00
Price-to-Book (P/B) Ratio
2.05 0.91 0.32 0.55 2.12
Price-to-Free Cash Flow (P/FCF) Ratio
-0.48 -0.83 -0.48 -1.40 -10.13
Price-to-Operating Cash Flow Ratio
-0.48 -0.84 -0.53 -1.60 -11.64
Price-to-Earnings Growth (PEG) Ratio
0.04 0.03 -0.08 -0.16 -0.21
Price-to-Fair Value
2.05 0.91 0.32 0.55 2.12
Enterprise Value Multiple
-1.17 -0.62 -0.65 -1.71 -7.94
Enterprise Value
98.96M 75.95M 95.94M 241.35M 891.27M
EV to EBITDA
-1.18 -0.62 -0.65 -1.71 -7.94
EV to Sales
-38.06 21.10 0.00 32.18 0.00
EV to Free Cash Flow
-0.88 -0.83 -0.80 -1.96 -9.78
EV to Operating Cash Flow
-0.88 -0.84 -0.89 -2.24 -11.24
Tangible Book Value Per Share
1.26 8.28 18.29 32.25 51.01
Shareholders’ Equity Per Share
1.26 8.28 18.29 32.25 51.01
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 >-0.01 -0.03 >-0.01
Revenue Per Share
-0.12 0.36 0.00 0.77 0.00
Net Income Per Share
-5.99 -11.62 -15.57 -14.85 -13.80
Tax Burden
1.00 0.95 1.00 1.00 1.01
Interest Burden
1.14 0.99 1.00 1.00 1.00
Research & Development to Revenue
-34.76 21.52 0.00 11.89 0.00
SG&A to Revenue
-27.37 13.87 0.00 8.59 0.00
Stock-Based Compensation to Revenue
-4.99 4.88 0.00 3.36 0.00
Income Quality
0.73 0.74 0.70 0.74 0.67
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis